ClearPointNeuro

#ClearPoint Neuro Reports First Quarter 2026 Results - Read More Here: ir.clearpointneuro.com/news-events/pr… #CLPT

#ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint - Read More Here: ir.clearpointneuro.com/news-events/pr… #CLPT

Day 1 of #ASGCT2026 is in the books, and many of our partners in the therapy development space will be sharing findings enabled by #ClearPoint Neuro technology. Stop by to check out these abstracts, and visit us in Booth #1013 for demos + discussion! #CLPT

#ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - Read More Here: ir.clearpointneuro.com/news-events/pr… #CLPT

#ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint Read More Here: ir.clearpointneuro.com/news-events/pr… #CLPT

#ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Read More Here: ir.clearpointneuro.com/news-events/pr… #CLPT

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - Read More Here: ir.clearpointneuro.com/news-events/pr…

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 - Read More Here: ir.clearpointneuro.com/news-events/pr…

#ClearPoint Neuro is starting 2026 strong with a team of over 170 people focused entirely on Neuro. We’re excited to keep this momentum going and see what we can achieve together! #CLPT

#ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - Read more here: loom.ly/EfJuDX0 #CLPT

#ClearPoint Neuro was excited to take part in the recent #BIG10 Neurosurgery Research Consortium. Our new Chief Medical Officer - Dr. Paul Larson - got a chance to share his vision for advancing our Biologics and Drug Delivery development programs. #CLPT

ClearPoint Neuro Completes Acquisition of IRRAS - Read more here: loom.ly/ualabV8

ClearPoint Neuro Reports Third Quarter 2025 Results - Read More Here: loom.ly/8gwEkRA

ClearPoint Neuro Announces Agreement to Acquire IRRAS - Read More Here: loom.ly/dLij52s

We always appreciate the invitation to participate in the #ASSFN Stereotactic & Functional Neurosurgery Hands-on Course @ University of Colorado Anschutz. This year marks the debut of #ClearPoint’s new iCT-guidance option & 1.5T labeling for the #Prism Laser Therapy System. #CLPT

#ClearPoint has been named 1 of America’s Growth Leaders by TIME! This recognition highlights the growing impact of our team & products. Several key programs are converging to drive an increasing global impact, & we’re excited to see what’s next! #CLPT loom.ly/NuC_f2o

#ClearPoint Neuro has grown & evolved so much over these past several years. We have so much more planned looking ahead & now with the right team, resources, & partnerships in place. That is why we call this next chapter for us: Fast. Forward. #2025CNS #CLPT #DBS

It’s been another great #ESGCT meeting, and there’s still time to catch up with the #ClearPoint team at Booth C03 tomorrow. If you didn’t make it to the conference, we’re always available for an online meeting! #ESGCT2025 #CLPT

#ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles at Booth 545 - Read More Here: loom.ly/Fv4xNnk #2025CNS #CLPT #LITT #LaserTherapy #Glioblastoma #NeuroOncology #MedTech

Join our Biologics team this week at Booth C03 in Seville, Spain for #ESGCT to hear about our latest innovations and how #ClearPoint is leading the way for delivery of gene and cell therapies from discovery to commercialization! #ESGCT2025 #CLPT